4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with Lung Diseases, Obstructive in 1 studies
4-diphenylacetoxy-1,1-dimethylpiperidinium: muscarinic receptor antagonist; RN given refers to parent cpd; do not confuse abbreviation 4-DAMP with a similar cpd which does not contain dimethyl groups
4-DAMP(1+) : A quaternary ammonium salt obtained by formal methylation of the tertiary amino function of 4-diphenylacetoxy-N-methylpiperidine.
Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cazzola, M | 1 |
| Matera, MG | 1 |
| D'Amato, G | 1 |
| De Santis, D | 1 |
| Maione, S | 1 |
| Lisa, M | 1 |
| Cenicola, ML | 1 |
| Marmo, E | 1 |
1 other study available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Evidence of muscarinic receptor subtypes in airway smooth muscle of normal volunteers and of chronic obstructive pulmonary disease patients.
Topics: Atropine; Forced Expiratory Volume; Humans; Lung Diseases, Obstructive; Muscle, Smooth; Piperidines; | 1989 |